A report from the Centers for Medicare and Medicaid Services found that proprietary blood testing devices from Theranos often failed to meet the company’s accuracy standards, the Wall Street Journal reports.
According to the report, 29 percent of the quality-control checks were outside the range that Theranos considered acceptable.
Read more at the link below:
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.